| Dr Michael Paul Vietz, MD | |
|
3449 Wilkens Ave Ste 305, Baltimore, MD 21229 | |
| (410) 464-4125 | |
| (410) 644-6232 |
| Full Name | Dr Michael Paul Vietz |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 3449 Wilkens Ave Ste 305, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194859108 | NPI | - | NPPES |
| 774011500 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0041539 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Agnes Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seton Medical Group Inc | 7416037924 | 75 |
| St. Agnes Healthcare, Inc. | 9830092733 | 237 |
News Archive
Older individuals who live at home but are dependent on healthcare services perceive their care delivery system to be effective when it involves supportive and reliable services, indicate UK study results.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.
Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 6 days ago
| Entity Name | Baltimore Medical System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700882503 PECOS PAC ID: 5395653455 Enrollment ID: O20031121000651 |
News Archive
Older individuals who live at home but are dependent on healthcare services perceive their care delivery system to be effective when it involves supportive and reliable services, indicate UK study results.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.
Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 6 days ago
| Entity Name | St. Agnes Healthcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144250176 PECOS PAC ID: 9830092733 Enrollment ID: O20040128001146 |
News Archive
Older individuals who live at home but are dependent on healthcare services perceive their care delivery system to be effective when it involves supportive and reliable services, indicate UK study results.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.
Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 6 days ago
| Entity Name | Seton Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144409194 PECOS PAC ID: 7416037924 Enrollment ID: O20080122000384 |
News Archive
Older individuals who live at home but are dependent on healthcare services perceive their care delivery system to be effective when it involves supportive and reliable services, indicate UK study results.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.
Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 6 days ago
| Entity Name | Obhg Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851657894 PECOS PAC ID: 3577728211 Enrollment ID: O20120703000447 |
News Archive
Older individuals who live at home but are dependent on healthcare services perceive their care delivery system to be effective when it involves supportive and reliable services, indicate UK study results.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.
Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Paul Vietz, MD 3449 Wilkens Ave Ste 305, Baltimore, MD 21229-5218 Ph: (410) 464-4125 | Dr Michael Paul Vietz, MD 3449 Wilkens Ave Ste 305, Baltimore, MD 21229 Ph: (410) 464-4125 |
News Archive
Older individuals who live at home but are dependent on healthcare services perceive their care delivery system to be effective when it involves supportive and reliable services, indicate UK study results.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.
Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.
Scientists at the European Molecular Biology Laboratory and the German Cancer Research Centre, both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes.
› Verified 6 days ago
Miss Elizabeth Unique Morris, MSN, WHNP-BC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 N Howard St, Baltimore, MD 21201 Phone: 410-576-1414 | |
Christine E. O Connor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 227 Saint Paul St, 6th Floor, Baltimore, MD 21202 Phone: 410-332-9002 Fax: 410-783-5880 | |
Fateh Hraky Sr., Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Suite 301, Baltimore, MD 21225 Phone: 410-350-0800 | |
Joyce A Bonsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3449 Wilkens Ave Ste 305, Baltimore, MD 21229 Phone: 410-644-2582 Fax: 410-644-6232 | |
Fouad M Abbas, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2411 W Belvedere Ave, Suite 206, Baltimore, MD 21215 Phone: 410-601-9030 | |
Dr. Ginny M Merryman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6569 N Charles St, Suite 501, Baltimore, MD 21204 Phone: 410-938-8960 Fax: 410-583-9770 | |
Dr. Golsa Mirmiran Yazdy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave Bldg A1, Baltimore, MD 21224 Phone: 410-550-0337 Fax: 410-550-0196 |